January 9, 2025 · Form 4 insider transaction
Wettig Thane bought 1,300,000 shares of FibroGen Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
The option vests in equal amount quarterly over 4 years measured from 1/9/2025.